170 related articles for article (PubMed ID: 9274521)
41. [Dysfunction of E-cadherin due to mutation of beta-catenin in a scirrhous gastric cancer cell line].
Kawanishi J; Kato J; Sasaki K; Fujii S; Watanabe N; Niitsu Y
Nihon Rinsho; 1995 Jul; 53(7):1590-4. PubMed ID: 7629993
[TBL] [Abstract][Full Text] [Related]
42. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment.
Brabletz T; Jung A; Reu S; Porzner M; Hlubek F; Kunz-Schughart LA; Knuechel R; Kirchner T
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10356-61. PubMed ID: 11526241
[TBL] [Abstract][Full Text] [Related]
43. The role of the E-cadherin/catenin complex in gastrointestinal cancer.
Debruyne P; Vermeulen S; Mareel M
Acta Gastroenterol Belg; 1999; 62(4):393-402. PubMed ID: 10692769
[TBL] [Abstract][Full Text] [Related]
44. APC, beta-catenin, and E-cadherin and the development of recurrent endometrial carcinoma.
Pijnenborg JM; Kisters N; van Engeland M; Dunselman GA; de Haan J; de Goeij AF; Groothuis PG
Int J Gynecol Cancer; 2004; 14(5):947-56. PubMed ID: 15361208
[TBL] [Abstract][Full Text] [Related]
45. Dysregulation of beta-catenin is common in canine sporadic colorectal tumors.
McEntee MF; Brenneman KA
Vet Pathol; 1999 May; 36(3):228-36. PubMed ID: 10332831
[TBL] [Abstract][Full Text] [Related]
46. Dysregulation of the E-cadherin/catenin complex by irreversible mutations in human carcinomas.
Berx G; Nollet F; van Roy F
Cell Adhes Commun; 1998; 6(2-3):171-84. PubMed ID: 9823469
[TBL] [Abstract][Full Text] [Related]
47. Adenomatous polyposis coli gene, beta-catenin, and E-cadherin expression in proximal and distal gastric cancers and precursor lesions: an immunohistochemical study using tissue microarrays.
Gulmann C; Grace A; Leader M; Butler D; Patchett S; Kay E
Appl Immunohistochem Mol Morphol; 2003 Sep; 11(3):230-7. PubMed ID: 12966349
[TBL] [Abstract][Full Text] [Related]
48. Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colon.
Hardy RG; Tselepis C; Hoyland J; Wallis Y; Pretlow TP; Talbot I; Sanders DS; Matthews G; Morton D; Jankowski JA
Gut; 2002 Apr; 50(4):513-9. PubMed ID: 11889072
[TBL] [Abstract][Full Text] [Related]
49. NH2-terminal deletion of beta-catenin results in stable colocalization of mutant beta-catenin with adenomatous polyposis coli protein and altered MDCK cell adhesion.
Barth AI; Pollack AL; Altschuler Y; Mostov KE; Nelson WJ
J Cell Biol; 1997 Feb; 136(3):693-706. PubMed ID: 9024698
[TBL] [Abstract][Full Text] [Related]
50. Abnormalities of the cadherin-catenin complex in chemically-induced colo-rectal carcinogenesis.
Tucker E; Buda A; Janghra B; Cpoad J; Moorghan M; Havler M; Dettmar P; Pignatelli M
Proc Nutr Soc; 2003 Feb; 62(1):229-36. PubMed ID: 12756972
[TBL] [Abstract][Full Text] [Related]
51. Alteration of beta-catenin expression in esophageal squamous-cell carcinoma.
Ninomiya I; Endo Y; Fushida S; Sasagawa T; Miyashita T; Fujimura T; Nishimura G; Tani T; Hashimoto T; Yagi M; Shimizu K; Ohta T; Yonemura Y; Inoue M; Sasaki T; Miwa K
Int J Cancer; 2000 Mar; 85(6):757-61. PubMed ID: 10709091
[TBL] [Abstract][Full Text] [Related]
52. E-cadherin as a tumor (invasion) suppressor gene.
Birchmeier W
Bioessays; 1995 Feb; 17(2):97-9. PubMed ID: 7748170
[TBL] [Abstract][Full Text] [Related]
53. Alterations of E-cadherin and beta-catenin in gastric cancer.
Huiping C; Kristjansdottir S; Jonasson JG; Magnusson J; Egilsson V; Ingvarsson S
BMC Cancer; 2001; 1():16. PubMed ID: 11747475
[TBL] [Abstract][Full Text] [Related]
54. Transcriptional impairment of beta-catenin/E-cadherin complex is not associated with beta-catenin mutations in colorectal carcinomas.
Garinis GA; Spanakis NE; Menounos PG; Manolis EN; Peros G
Br J Cancer; 2003 Jan; 88(2):206-9. PubMed ID: 12610504
[TBL] [Abstract][Full Text] [Related]
55. Molecular histology in the study of solid tumours.
Campbell RJ; Pignatelli M
Mol Pathol; 2002 Apr; 55(2):80-2. PubMed ID: 11950953
[TBL] [Abstract][Full Text] [Related]
56. Defective E-cadherin/catenin complexes in human cancer.
Van Aken E; De Wever O; Correia da Rocha AS; Mareel M
Virchows Arch; 2001 Dec; 439(6):725-51. PubMed ID: 11787845
[TBL] [Abstract][Full Text] [Related]
57. The gene for the APC-binding protein beta-catenin (CTNNB1) maps to chromosome 3p22, a region frequently altered in human malignancies.
Trent JM; Wiltshire R; Su LK; Nicolaides NC; Vogelstein B; Kinzler KW
Cytogenet Cell Genet; 1995; 71(4):343-4. PubMed ID: 8521721
[TBL] [Abstract][Full Text] [Related]
58. APC, beta-Catenin and hTCF-4; an unholy trinity in the genesis of colorectal cancer.
Bright-Thomas RM; Hargest R
Eur J Surg Oncol; 2003 Mar; 29(2):107-17. PubMed ID: 12633551
[TBL] [Abstract][Full Text] [Related]
59. The cadherin-catenin system: implications for growth and differentiation of endocrine tissues.
Pötter E; Bergwitz C; Brabant G
Endocr Rev; 1999 Apr; 20(2):207-39. PubMed ID: 10204118
[TBL] [Abstract][Full Text] [Related]
60. Mutational analysis of E-cadherin, β-catenin and APC genes in synovial sarcomas.
Subramaniam MM; Calabuig-Fariñas S; Pellin A; Llombart-Bosch A
Histopathology; 2010 Sep; 57(3):482-6. PubMed ID: 20840677
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
